HC Wainwright & Co. Reiterates Buy on Omega Therapeutics, Maintains $11 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Robert Burns reiterated a Buy rating on Omega Therapeutics (NASDAQ:OMGA) and maintained an $11 price target.
June 06, 2023 | 10:21 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Omega Therapeutics (NASDAQ:OMGA) receives a reiterated Buy rating from HC Wainwright & Co. analyst Robert Burns, with a maintained $11 price target.
The reiterated Buy rating and maintained $11 price target by HC Wainwright & Co. analyst Robert Burns indicates a positive outlook for Omega Therapeutics (NASDAQ:OMGA) in the short term. This news is likely to be perceived positively by investors, potentially leading to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100